atropine has been researched along with isoniazid in 31 studies
Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) | Studies (isoniazid) | Trials (isoniazid) | Recent Studies (post-2010) (isoniazid) |
---|---|---|---|---|---|
26,711 | 1,259 | 1,697 | 21,815 | 960 | 4,493 |
Protein | Taxonomy | atropine (IC50) | isoniazid (IC50) |
---|---|---|---|
Myeloperoxidase | Homo sapiens (human) | 4.85 | |
Enoyl-[acyl-carrier-protein] reductase [NADH] | Mycobacterium tuberculosis H37Rv | 8.29 | |
Putative FAD-containing monooxygenase MymA | Mycobacterium tuberculosis H37Rv | 4.9 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 17 (54.84) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (19.35) | 29.6817 |
2010's | 8 (25.81) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Beech, J | 1 |
Reidenberg, MM | 1 |
Tuttle, RS | 2 |
Ganshorn, A; Kurz, H | 1 |
Greengard, P; Quinn, GP; Reid, MB | 1 |
Stoliarov, GV | 1 |
Breunig, HL; Broadlick, DE; Comer, JP; Sampson, CB | 1 |
Frank, RN; Green, WR; Ryan, SJ | 1 |
Sidenur, VG | 1 |
Arrell, RW | 1 |
JOERGENSEN, G | 1 |
FUJIMOTO, F | 1 |
SEIFERT, G | 1 |
Brzin, M; Erzen, I | 1 |
Garcia Mendes, E; Scemes, E | 1 |
BARRNETT, RJ; LENTZ, TL | 1 |
3 review(s) available for atropine and isoniazid
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Principles of therapy.
Topics: Adrenal Cortex Hormones; Aerosols; Ampicillin; Animals; Atropine; Bronchodilator Agents; Chloramphenicol; Cromolyn Sodium; Horse Diseases; Horses; Isoniazid; Oxytetracycline; Penicillins; Pyrilamine; Respiratory Tract Diseases | 1979 |
[PHARMACOGENETICS].
Topics: Abnormalities, Drug-Induced; Atropine; Cleft Palate; Cortisone; Genetics; Glucosephosphate Dehydrogenase Deficiency; Glucosephosphates; Isoniazid; Mutation; Oxidoreductases; Pharmaceutical Preparations; Pharmacogenetics; Pharmacology; Primaquine; Thalidomide; Toxicology | 1964 |
28 other study(ies) available for atropine and isoniazid
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Obesity and fasting--effects on drug metabolism and drug action in man.
Topics: Adult; Animals; Antipyrine; Atropine; Blood Proteins; Fasting; Female; Humans; Isoniazid; Obesity; Pharmaceutical Preparations; Procaine; Protein Binding; Sulfisoxazole; Tolbutamide | 1977 |
Relationship between blood histamine and centrally evoked hypotensive response.
Topics: Animals; Atropine; Blood; Carotid Arteries; Cats; Chlorpheniramine; Histamine Release; Histidine; Hypotension; Iliac Artery; Isoniazid; Medulla Oblongata; p-Methoxy-N-methylphenethylamine; Physostigmine; Vasodilator Agents; Vasomotor System | 1965 |
[Differences between the protein binding of newborns and adults and their importance for pharmacological action].
Topics: Acetaminophen; Age Factors; Aminosalicylic Acids; Atropine; Chloramphenicol; Humans; Infant, Newborn; Isoniazid; Methicillin; Morphine; Nitrofurantoin; Oxyphenbutazone; Phenacetin; Phenobarbital; Phenytoin; Promethazine; Protein Binding; Salicylates; Sulfadimethoxine; Thiopental | 1968 |
Prevention by antidepressant drugs of reserpine effect on pyridine nucleotide metabolism.
Topics: Aminopyrine; Amitriptyline; Amphetamine; Animals; Antidepressive Agents; Atropine; Benactyzine; Caffeine; Chlorpheniramine; Chlorpromazine; Female; Hexobarbital; Hydralazine; Hypothalamus; Imipramine; Iproniazid; Isoniazid; Liver; Meprobamate; Methacholine Compounds; Morphine; NAD; Niacinamide; Pargyline; Pentobarbital; Phenylbutazone; Phenytoin; Quinacrine; Rats; Reserpine; Tranylcypromine; Tripelennamine; Zoxazolamine | 1966 |
[On the course of drug psychoses].
Topics: Adrenocorticotropic Hormone; Adult; Atropine; Barbiturates; Chlorpromazine; Disulfiram; Drug Hypersensitivity; Female; Humans; Isoniazid; Male; Prednisolone; Psychoses, Substance-Induced; Quinacrine; Time Factors | 1968 |
Estimation of mean potency and content uniformity of tablets: a new approach.
Topics: Atropine; Caffeine; Chemistry, Pharmaceutical; Computers; Diethylstilbestrol; Drug Compounding; Drug Tolerance; Isoniazid; Mestranol; Methyltestosterone; Models, Theoretical; Paramethasone; Pharmaceutical Preparations; Phenobarbital; Sulfates; Tablets | 1970 |
Bilateral inflammatory pseudotumors of the ciliary body.
Topics: Administration, Topical; Anti-Inflammatory Agents; Atropine; Biopsy; Ciliary Body; Diagnosis, Differential; Eye Diseases; Eye Neoplasms; Humans; Inflammation; Isoniazid; Lymphoma; Male; Melanoma; Middle Aged; Mycoses; Neoplasm Metastasis; Prednisolone; Prednisone; Sarcoidosis; Tuberculosis, Ocular | 1971 |
Drug toxicity of genetic origin.
Topics: Atropine; Barbiturates; Catalase; Drug Hypersensitivity; Humans; Isoniazid; Primaquine; Succinylcholine | 1969 |
Evidence for histaminergic nerves in the pyramidal cat.
Topics: Animals; Atropine; Carbon Dioxide; Carotid Sinus; Cats; Chlorpheniramine; Histamine; Isoniazid; Norepinephrine; p-Methoxy-N-methylphenethylamine; Pyramidal Tracts; Reflex; Sympathetic Nervous System; Vasomotor System | 1966 |
Acute tuberculous panophthalmitis.
Topics: Acetazolamide; Aged; Aminosalicylic Acids; Atropine; Choroid Neoplasms; Exophthalmos; Female; Glaucoma; Granuloma; Humans; Isoniazid; Male; Panophthalmitis; Retina; Tuberculosis, Ocular; Tuberculosis, Pulmonary; Uveitis | 1967 |
[THE EFFECTS OF AUTONOMIC FUNCTION ON SERUM ISONIAZID CONCENTRATION AFTER IT'S ADMINISTRATION IN RABBITS].
Topics: Adrenocorticotropic Hormone; Atropine; Autonomic Nervous System; Blood Chemical Analysis; Chlorpromazine; Epinephrine; Imidazoles; Isoniazid; Neostigmine; Pharmacology; Physiology; Rabbits; Research; Reserpine; Tetraethylammonium Compounds; Tyramine | 1963 |
[EXPERIMENTAL PATHOMORPHOLOGY OF THE SALIVARY DUCT SYSTEM].
Topics: Acid Phosphatase; Alkaline Phosphatase; Antineoplastic Agents; Atropine; Carbonic Anhydrases; Dihydrotachysterol; Electron Transport Complex II; Histocytochemistry; Iodides; Isoniazid; Isoproterenol; Monoamine Oxidase Inhibitors; Norepinephrine; Pathology; Pharmacology; Pilocarpine; Rats; Research; Salivary Ducts; Salivary Glands; Serotonin; Succinate Dehydrogenase | 1963 |
Cholinergic mechanisms in hydra.
Topics: Acetylcholine; Animals; Atropine; Choline O-Acetyltransferase; Cholinesterase Inhibitors; Cholinesterases; Epinephrine; Hexamethonium Compounds; Hydra; Movement; Tubocurarine | 1978 |
Cholinergic mechanism in Liriope tetraphylla (Cnidaria, Hydrozoa).
Topics: Animals; Atropine; Cholinesterases; Hydra; Receptors, Cholinergic; Synaptic Transmission; Time Factors | 1986 |
THE ROLE OF THE NERVOUS SYSTEM IN REGENERATING HYDRA: THE EFFECT OF NEUROPHARMACOLOGICAL AGENTS.
Topics: Amphetamine; Amphetamines; Animals; Atropine; Autonomic Agents; Biphenyl Compounds; Chlorpromazine; Cnidaria; Decamethonium Compounds; Dihydroxyphenylalanine; Enzyme Inhibitors; Ergotamine; Hexamethonium Compounds; Histocytochemistry; Histology; Hydra; Isoflurophate; Lidocaine; Methyldopa; Nervous System; Pharmacology; Physostigmine; Regeneration; Research; Reserpine; Tubocurarine | 1963 |